![Irene Clement](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Irene Clement
General Counsel at ID Biomedical Corp.
Profile
Irene Clement is currently the Vice President of Regulatory Affairs at ID Biomedical Corp.
Prior to this, she worked as the Acting Vice President of Regulatory Affairs at Medicago, Inc. from 2011 to 2013.
She obtained an undergraduate degree from the University of Calgary.
Irene Clement active positions
Companies | Position | Start |
---|---|---|
ID Biomedical Corp.
![]() ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | General Counsel | - |
Former positions of Irene Clement
Companies | Position | End |
---|---|---|
Medicago, Inc.
![]() Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | General Counsel | - |
Training of Irene Clement
University of Calgary | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
ID Biomedical Corp.
![]() ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Health Technology |
Medicago, Inc.
![]() Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Health Technology |
- Stock Market
- Insiders
- Irene Clement